Jefferies Group LLC Viking Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2019 May 15, 2019	BUY	$7.58 - $9.94 $94,750 - $124,250	12,500 Added 31.25%	52,500 $522,000
Q4 2018 Feb 14, 2019	SELL	$7.16 - $16.21 $74,464 - $168,584	-10,400 Reduced 20.63%	40,000 $306,000
Q3 2018 Nov 14, 2018	BUY	$9.7 - $19.65 $388,000 - $786,000	40,000 Added 384.62%	50,400 $878,000
Q2 2018 Aug 14, 2018	BUY	$3.88 - $12.74 $40,352 - $132,496	10,400 New	10,400 $99,000

473

66.2M

5.72M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.03B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.